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Oral squamous cell carcinoma (SCC) are characterized by a high
degree of local invasiveness and a high rate of metastasis to
cervical lymph nodes, but a low rate of metastases to distant
organs. To successfully establish a metastasis, tumour cells must
leave the primary site, invade the local host tissue, enter the circu-
lation (intravasation), arrest at the distant vascular bed, extravasate
and proliferate at the distant organ site (Fidler, 1990; Liotta and
Stetler-Stevenson, 1991; Aznavoorian et al, 1993). Therefore, if
we can evaluate the capability of the tumour cells for intravasa-
tion, extravasation and survival in the circulation, we might
predict the metastatic potential of the tumour cells in oral SCC
patients. In the present study, we examined the expression of
cytokeratin 20 (CK20) mRNA in the peripheral blood by reverse
transcriptase polymerase chain reaction (RT-PCR) to see the
accomplishment of the intravasation of cancer cells and the
survival of cancer cells in the circulation.
PATIENTS, MATERIALS AND METHODS
Patients
We studied 12 patients. Site of origin, TNM classification at first
visit, histopathological diagnosis, lymph node metastasis, and
survival periods of the patients are shown in Table 1. Fourteen
blood samples from healthy volunteers and three patients with
inflammatory lesions of the oral mucosa were subjected to the
study.
Cells and cell culture
BHY, HN, HNt (Kawamata et al, 1997) and IH (Harada et al,
unpublished data) cells are all derived from human oral SCC
tumours from the patients. TYS is a human oral adenosquamous
carcinoma cell line established in our laboratory (Yanagawa et al,
1986). Gingival epithelial cells (GE) and gingival fibroblasts (GF)
are cultured from a normal human gingival tissue. All of the cells
were maintained in Dulbecco’s modified Eagle medium (DMEM)
(Gibco BRL, Gaithersburg, MD, USA) supplemented with 10%
fetal calf serum (FCS) (Gibco), 100 mg ml–1 streptomycin, and
100 U ml–1 penicillin (Gibco) in a humidified atmosphere of 95%
air and 5% carbon dioxide at 37°C.
Blood samples
Venous blood (5 ml) from patients and healthy volunteers was
collected by puncturing the skin with a Jelco i.v. catheter (Johnson
& Johnson Medical, Tokyo), which consisted of an inner metal
needle and an outer elastic catheter. To avoid the contamination of
the blood with skin fragments, the first 1 ml of blood samples
drawn from the inner needle were discarded with the needle.
Subsequently, blood samples (5 ml) drawn from the outer catheter
were collected in the tubes containing 5 mg EDTA. Twenty milli-
litres of a haemolytic buffer (10 mM potassium bicarbonate,
155 mM ammonium chloride, 0.1 mM EDTA) was added to the
blood samples. Thirty minutes after incubation on ice, the tubes
were centrifuged at 3000 g for 10 min at room temperature. The
haemolytic reaction was repeated three times. The pellets were
washed with 100 mM phosphate-buffered saline (pH 7.4) twice,
and were subjected to the RNA extraction procedure. RNA was
extracted by NP-40 hypotonic method (Kawamata et al, 1997) or
by Isogen RNA extracting mixture (Nippon Gene, Toyama,
Japan). When intact 28S and 18S ribosomal RNAs in the extracted
total RNA could be visualized on formaldehyde denaturing
agarose gel, 5 mg of total RNAs from the samples were subjected
to RT-PCR.
Reverse transcriptase polymerase chain reaction
Five micrograms cytoplasmic or total RNA was reverse tran-
scribed by Molony Murine Leukemia Virus reverse transcriptase
(Gibco) at 42°C for 60 min using random primer (5 mM; Gibco) in
20 ml of the reaction mixture. Subsequently, 1 ml of the product
was subjected to the PCR amplification. PCR was performed as
Short communication
Haematogenous cytokeratin 20 mRNA as a predictive
marker for recurrence in oral cancer patients
H Kawamata, D Uchida, K Nakashiro, S Hino, F Omotehara, H Yoshida and M Sato
Second Department of Oral and Maxillofacial Surgery, Tokushima University School of Dentistry, Tokushima 770, Japan
Summary We examined the expression of cytokeratin 20 (CK20) mRNA in the peripheral blood of oral squamous cell carcinoma (SCC)
patients by reverse transcriptase polymerase chain reaction (RT-PCR). Eleven out of 12 oral SCC patients showed positive RT-PCR results.
However, there is no clear relationship between the haematogenous CK20 mRNA and the metastasis. After initial treatment, all of the tumour-
free survivors tested showed negative RT-PCR results. CK20 mRNA in peripheral blood can be used as a marker for tumour recurrence but
not for metastasis in oral SCC patients.
Keywords: oral cancer; CK20; recurrence; metastasis
448
British Journal of Cancer (1999) 80(3/4), 448–452
© 1999 Cancer Research Campaign
Article no. bjoc.1998.0377
Received 27 November 1997
Revised 15 June 1998
Accepted 29 July 1998
Correspondence to: H KawamataCK20 in oral SCC patients 449
British Journal of Cancer (1999) 80(3/4), 448–452 © Cancer Research Campaign 1999
follows: the final concentration of dNTPs and primers in the reac-
tion mixture was 200 mM and 1 mM respectively. Taq DNA poly-
merase (Takara, Otsu, Japan) was added to the mixture at a final
concentration of 0.05 U ml–1 and the reaction was carried out in
Takara Thermal Cycler MP (Takara). The PCR condition was as
follows: for glyceraldehyde phosphate dehydrogenase (GAPDH)
amplification, 94°C for 3 min and then 94°C for 1 min, 55°C for
1.5 min, 72°C for 2.5 min for 20 cycles and an extension of 72°C
for 4 min; for CK20 amplification from cultured cells or oral SCC
tissues, 94°C for 3 min and then 94°C for 1 min, 60°C for 1.5 min,
72°C for 2.5 min for 40 cycles and an extension of 72°C for 4 min.
For CK20 amplification from blood samples, two-round PCR was
used. The conditions were as follows: 94°C for 3 min and then
94°C for 1 min, 65°C for 1.5 min, 72°C for 2.5 min for 30 cycles
and an extension of 72°C for 4 min, and then 1 ml aliquots of first-
round PCR products were subjected to the second amplification
using the same primers and the same conditions. The primers used
were: CK20-UP, 5¢-CAGACACACGGTGAACTA-3¢ (Burchill et
al, 1995a), for CK20-DN, 5¢-GATCAGCTTCCACTGTTAGAC-
3¢ (Buchill et al, 1995a) for CK20 amplification; GAPDH-UP,
5¢-GAAATCCCATCACCATCTTCCAGG-3¢, and GAPDH-DN,
5¢-CATGTGGGCCATGAGGTCCACCAC-3¢ for GAPDH ampli-
fication.
Cell spiking
HNt cells (10–1000) were added to 5 ml of whole blood samples
from a healthy male volunteer, total RNA was extracted from the
cell-spiked blood samples, and RT-PCR for CK20 mRNA was
performed.
Southern blot analysis
RT-PCR products were separated on 1% agarose gels and Southern
blot analysis was carried out by the standard method. The probe
used was a digoxigenin-labelled oligonucleotide probe CK20-
PR (5¢-ATACTTCAGTCTGAAGTCCTCAGCAGCCAG-3¢), the
sequence of which lay between a pair of amplifying primers
CK20-UP and CK20-DN.
Ethical standards
This study has been approved by the ethical committee of
Tokushima University School of Dentistry. The patients gave their
informed consent before their inclusion in this study.
RESULTS
Site of origin and clinical details of oral SCC patients
The clinicopathological details of the patients are shown in Table
1. Twelve blood samples from P1 to P12, and seven fresh cancer
samples from P4, P6, P12 and P13–P16 were available.
RT-PCR detection of CK20 mRNA in human oral SCC
cells and human oral SCC tissues
RT-PCR for CK20 mRNA generated a 370-bp band on agarose
gel, but some non-specific extra bands appeared on TYS and HNt
cells (Figure 1). Southern blot analysis revealed that only a 370-bp
band was hybridized with the CK20 specific probe (data not
shown). CK20 mRNA was expressed in all of the oral SCC cells
Table 1 Site of origin and clinical details of oral SCC patients
Patients Site of origin TNM pTNM Primary Histopathology
Clinical details
or of original tumour Metastasisa Survival
recurrent (lymph node)
P1 Tongue T4N0M0 pT4N0MX Recurrent Invasive SCC No Dead (11mb)
P2 Mandibular gingiva T3N1M0 pT3NXMX Primary Invasive SCC ND Alive (1 y 2 m)
P3 Tongue T1N0M0 pT1N2MX Primary Invasive SCC Yes Alive (1 y 7 m)
P4 Floor of mouth T2N0M0 pT2N1MX Primary Basaloid SCC Yes Alive (1 y 2 m)
P5 Mandibular gingiva T2N0M0 pT2N1MX Primary Invasive SCC Yes Alive (1 y 4 m)
P6 Mandibular gingiva T2N0M0 pT2N0MX Recurrent Early invasive SCC No Dead (1 y 8 m)
P7 Maxillary gingiva T2N0M0 pT2N0MX Primary Invasive SCC No Alive (10 m)
P8 Tongue T3N0M0 pT2N0MX Primary Early invasive SCC No Alive (9 m)
P9 Tongue T1N0M0 pT2NXMX Primary Early invasive SCC ND Alive (7 m)
P10 Maxillary gingiva T3N1M0 pT3NXMX Primary Invasive SCC NI Alive (7 m)
P11 Mandibular gingiva T2N2aM0 pT2N0MX Recurrent Invasive SCC No Alive (2 y 11 m)
P12 Maxillary gingiva T2N0M0 pT2N1MX Recurrent Invasive SCC Yes Dead (2 y 5 m)
P13 Soft palate T3N2M0 pT3N1MX Primary Invasive SCC Yes Alive (1 y 8 m) 
P14 Tongue T2N1M0 pT2N0MX Primary Invasive SCC No Alive (2 y 5 m)
P15 Mandibular gingiva T3N1M0 pT3NXMX Primary Invasive SCC NI NI
P16 Buccal mucosa T2N0M0 pT2NXMX Primary Invasive SCC ND Alive (1 y 7 m)
aYes, lymph node metastasis was confirmed by histopathology; No, lymph node metastasis was not detected in the operation materials by histopathology; ND,
metastasis was not detectable clinically in the observed periods; NI, not informative. bObserved periods from the first visit (y, years; m, months).450 H Kawamata et al
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(HN, BHY, HNt, IH), one of the salivary adenosquamous cancer
cells (TYS), placental tissue and gingival epithelial cells (GE), but
not in peripheral blood cells collected from a healthy man (NB) and
gingival fibroblasts (GF) (Figure 1A). Moreover, CK20 mRNA
was expressed in all of the oral SCC tissues (Figure 1B). Although
CK20 fragments could be amplified by 25–30 cycles with 55°C
annealing temperature, some extra bands appeared on the gel.
Therefore, we used the condition described in the Materials and
methods section (40 cycles with 60°C annealing temperature) to
obtain the clear band. GAPDH as an internal control was amplified
in all of the samples tested (Figure 1). No amplification was
observed in water control samples (B) (Figure 1).
Control blood analysis and cell spiking
In 17 control blood samples collected from 14 healthy volunteers
and three patients with inflammatory lesions of the oral mucosa,
CK20 mRNA was not amplified after two rounds of PCR,
however GAPDH mRNA was clearly amplified in all of the blood
samples after one round of PCR (data not shown). To test the
sensitivity of the technique to detect circulating cancer cells in
peripheral blood, a cell spiking experiment was performed. We
could detect down to 1 ´ 102 HNt cells diluted in 5 ml of whole
human blood collected from a healthy man (Figure 2). The 370-bp
band on agarose gel electrophoresis was confirmed as the CK20
fragment by Southern blot analysis (data not shown). Southern
blot analysis did not increase the sensitivity of the assay, but
increased the specificity (data not shown). In this PCR reaction,
we also used high annealing temperature (65°C) and high cycle
numbers (30 plus 30 cycles) to clearly amplify the specific band
and to diminish the extra bands. Nested-PCR may be more suitable
to amplify such a small amount of mRNA specifically, however
we obtained the specific band only in the cell spiking samples but
not in the control samples by this method and the band was
confirmed as the CK20 fragment by Southern blot analysis. We,
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Figure 1 Amplification of CK20 mRNA from several human oral SCC cell
lines (A) and human oral SCC tissues (B) by RT-PCR. Five micrograms
cytoplasmic RNA was reverse-transcribed by M-MLV, and 1 ml of product in a
20-ml reaction was subjected to the PCR amplification. PCR products were
separated on 1.5% agarose gels, and stained with ethidium bromide. HN,
BHY, HNt, IH: human oral SCC cell lines; TYS: human adenosquamous cell
line; placenta: normal placental tissue; NB: normal blood sample; GE:
gingival epithelial cells; GF: gingival fibroblasts; B: blank (no RNA); P4, P6,
P12, P13–P16: oral cancer tissues; NG1 and NG2: normal gingiva; pBK-
Pvu2: molecular weight marker; Pvu 2-digested pBK-CMV plasmid (2878,
1026, 608 bp)
Figure 2 Amplification of CK20 mRNA from blood samples spiked with HNt
cells by RT-PCR. HNt cells (10–1000) were added to 5 ml of whole blood
samples from a healthy male volunteer, total RNA was extracted from the
cell-spiked blood samples, and 5 mg of total RNA was subjected to RT-PCR.
101, 102, 103: HNt cell number which was added to the blood samples.
Molecular weight markers (2878, 1026, 608 bp) were loaded on the first laneCK20 in oral SCC patients 451
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therefore, believed that our technique used in this experiment
detected the CK20 mRNA as specifically as nested-PCR did.
Detection of CK20 mRNA in the blood samples
collected from oral SCC patients
Contrary to our expectation, we detected CK20 mRNA in 11 out of
12 oral SCC patients, including eight primary cancer patients and
three recurrent patients in their peripheral blood samples (Figure
3). However, there is no clear relationship between the haema-
togenous CK20 mRNA and cancer metastasis of oral SCC
patients. Only one recurrent patient (P6) who had multiple but
early invasive SCC on the mandibular gingiva showed negative
results for CK20 mRNA amplification in her peripheral blood
sample (Figure 3). GAPDH was clearly amplified in all of the
samples tested, and no amplification was observed in water control
samples (Figure 3). We examined tumour-free survivors (P2, P4,
P5, P7, P8 and P9) for CK20 mRNA again in their peripheral
blood, 3–16 months after initial treatment (radiation,
chemotherapy and operation). All of the patients tested showed
negative RT-PCR results for CK20 mRNA (data not shown). We
repeated all of the experiments at least three times, and obtained
the same results.
DISCUSSION
Most of the oral SCC cells showed muscular invasion, bone inva-
sion and vascular invasion (lymphatic channels and microvessels)
at very early stage. We sometimes observed intravascular tumour
embolus on the biopsy materials obtained from oral SCC patients.
These observations suggest that oral SCC cells may easily
intravasate into the circulation. In fact, we have detected CK20
mRNA in peripheral blood samples collected from 11 out of 12
cases of oral SCC patients as evidence for the existence of cancer
cells in the circulation. Several groups have reported use of the
RT-PCR method to detect prostatic cancer cells (Fadlon et al,
1996; Henke et al, 1997; Melchior et al, 1997), melanoma
cell (Foss et al, 1995), and neuroblastoma cells (Burchill et al,
1995b) in peripheral blood by amplifying prostatic specific
antigen, tyrosinase and tyrosine hydroxylase respectively. Some
investigators used the epithelium-specific cytokeratin (CK8,
CK19 or CK20) as a marker for detecting epithelial cancer cells
which did not have any specific markers (Burchill et al, 1995a;
Krismann et al, 1995; Soeth et al, 1996). However, Burchill et al
(1995a) and Krisman et al (1995) reported that CK8 and CK19
were amplified in a high proportion of normal peripheral blood
samples, but CK20 was not amplified in any normal blood
samples. In contrast, Moll et al (1992) reported that oral mucosa
and oral SCC rarely expressed CK20 protein when examined by
immunohistochemistry. However, we detected CK20 mRNA in all
of the oral SCC tissues as well as oral SCC-derived cell lines
tested when examined by RT-PCR and Southern blotting. These
discrepancies may be due to the different sensitivity of the method
used. Therefore, we decided to use the CK20 mRNA as a marker
for oral SCC cells in this experiment. CK20 mRNA was not
amplified in the peripheral blood samples collected from healthy
volunteers and was detected only in oral SCC patients when we
eliminated a contamination of the blood samples with skin
fragments as carefully as possible. However, there was no clear
relationship between the detection of haematogenous CK20
mRNA and cancer metastasis of the patients. These results suggest
that oral SCC cells may easily intravasate and the intravasation of
cancer cells was not critical step for metastasis formation of oral
SCC, but extravasation or ectopic growth potential of oral SCC
cells may be more important for their metastasis formation. We
examined CK20 mRNA in oral SCC patients 3–16 months after
initial treatment, all of the tumour-free survivors tested showed
negative RT-PCR results for CK20 mRNA. Thus, CK20 mRNA in
the peripheral blood from oral SCC patients cannot be a marker for
metastatic potentials of the cancer cells, but it can be used as a
marker for the evidence of tumour recurrence or the existence of
the metastatic tumours after initial treatment.
Although the number of samples examined in this experiment is
limited at this time, we detected circulating cancer cells in most of
the oral cancer-burdened patients, but in none of the tumour-free
survivors after treatment. These results suggest that haematoge-
nous cytokeratin 20 mRNA can be a marker for tumour recurrence
in oral squamous cell carcinoma patients.
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